News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
VEITINGER KLAUS R DR
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| VEITINGER KLAUS R DR (Director) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Granted 17,300 options to buy
@ $11.71, valued at
$202.6k
|
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| VEITINGER KLAUS R DR (Director) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Granted 16,300 options to buy
@ $4.53, valued at
$73.8k
|
|
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| VEITINGER KLAUS R DR (Director) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Granted 16,300 options to buy
@ $5.7, valued at
$92.9k
|
|
| 02/09/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 06/15/2020 |
4
| VEITINGER KLAUS R DR (Director) has filed a Form 4 on Tricida, Inc.|
Txns:
| Granted 5,670 shares
@ $0
Granted 22,967 options to buy
@ $25.4, valued at
$583.4k
|
|
| 06/11/2020 |
4
| VEITINGER KLAUS R DR (Director) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Granted 6,124 options to buy
@ $7.96, valued at
$48.7k
|
|
| 11/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2019 |
4
| VEITINGER KLAUS R DR (Director) has filed a Form 4 on Tricida, Inc.|
Txns:
| Sold 694 shares
@ $30.66, valued at
$21.3k
Sold 585 shares
@ $32.05, valued at
$18.7k
Sold 121 shares
@ $32.45, valued at
$3.9k
Sold 677 shares
@ $30.72, valued at
$20.8k
Sold 570 shares
@ $32.01, valued at
$18.2k
Sold 153 shares
@ $32.42, valued at
$5k
Sold 724 shares
@ $30.72, valued at
$22.2k
Sold 573 shares
@ $32.12, valued at
$18.4k
Sold 103 shares
@ $32.47, valued at
$3.3k
Exercised 1,400 options to buy
@ $0.8, valued at
$1.1k
|
|
| 08/28/2019 |
4
| VEITINGER KLAUS R DR (Director) has filed a Form 4 on Tricida, Inc.|
Txns:
| Sold 1,400 shares
@ $33.18, valued at
$46.5k
Sold 1,400 shares
@ $33.14, valued at
$46.4k
Sold 1,400 shares
@ $33.17, valued at
$46.4k
Exercised 1,400 options to buy
@ $0.8, valued at
$1.1k
|
|
| 07/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/09/2019 |
4
| VEITINGER KLAUS R DR (Director) has filed a Form 4 on Tricida, Inc.|
Txns:
| Sold 1,100 shares
@ $36.29, valued at
$39.9k
Sold 1,192 shares
@ $36.3, valued at
$43.3k
Sold 1,200 shares
@ $36.3, valued at
$43.6k
Exercised 1,100 options to buy
@ $0.8, valued at
$880 |
|
| 07/05/2019 |
4
| VEITINGER KLAUS R DR (Director) has filed a Form 4 on Tricida, Inc.|
Txns:
| Sold 3,100 shares
@ $36.91, valued at
$114.4k
Sold 3,008 shares
@ $36.89, valued at
$111k
Sold 3,000 shares
@ $36.91, valued at
$110.7k
Exercised 3,100 options to buy
@ $0.8, valued at
$2.5k
|
|
| 06/20/2019 |
4
| VEITINGER KLAUS R DR (Director) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Granted 6,124 options to buy
@ $3.37, valued at
$20.6k
|
|
| 06/04/2019 |
4
| VEITINGER KLAUS R DR (Director) has filed a Form 4 on Tricida, Inc.|
Txns:
| Granted 1,879 shares
@ $0
Granted 7,068 options to buy
@ $36.74, valued at
$259.7k
|
|
| 03/29/2019 |
4
| VEITINGER KLAUS R DR (Director) has filed a Form 4 on Tricida, Inc.|
Txns:
| Sold 22,100 shares
@ $34.19, valued at
$755.6k
Sold 22,100 shares
@ $34.19, valued at
$755.6k
Sold 22,100 shares
@ $34.18, valued at
$755.4k
Exercised 22,100 options to buy
@ $0.8, valued at
$17.7k
|
|
| 03/28/2019 |
4
| VEITINGER KLAUS R DR (Director) has filed a Form 4 on Tricida, Inc.|
Txns:
| Sold 4,000 shares
@ $23.85, valued at
$95.4k
Sold 4,000 shares
@ $23.84, valued at
$95.4k
Sold 4,000 shares
@ $23.8, valued at
$95.2k
Exercised 4,000 options to buy
@ $0.8, valued at
$3.2k
|
|
| 02/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/31/2018 |
4
| VEITINGER KLAUS R DR (Director) has filed a Form 4 on Tricida, Inc.|
Txns:
| Sold 997 shares
@ $23.63, valued at
$23.6k
Sold 700 shares
@ $23.78, valued at
$16.6k
Sold 740 shares
@ $23.74, valued at
$17.6k
Exercised 997 options to buy
@ $0.8, valued at
$797.6 |
|
| 12/28/2018 |
4
| VEITINGER KLAUS R DR (Director) has filed a Form 4 on Tricida, Inc.|
Txns:
| Sold 3,254 shares
@ $24.97, valued at
$81.3k
Sold 3,300 shares
@ $24.97, valued at
$82.4k
Sold 3,260 shares
@ $24.97, valued at
$81.4k
Exercised 3,254 options to buy
@ $0.8, valued at
$2.6k
|
|
| 07/02/2018 |
4
| VEITINGER KLAUS R DR (Director) has filed a Form 4 on Tricida, Inc.|
Txns:
| Granted 3,632 shares
@ $0
Granted 13,147 options to buy
@ $19, valued at
$249.8k
|
|
| 06/27/2018 |
3
| VEITINGER KLAUS R DR (Director) has filed a Form 3 on Tricida, Inc. |
| 06/21/2018 |
4
| VEITINGER KLAUS R DR (Director) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Granted 6,124 options to buy
@ $5.53, valued at
$33.9k
|
|
| 11/21/2017 |
3
| VEITINGER KLAUS R DR (Director) has filed a Form 3 on scPharmaceuticals Inc. |
| 11/27/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/12/2015 |
4
| VEITINGER KLAUS R DR (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS INC|
Txns:
| Sold 1,000 shares
@ $198.25, valued at
$198.3k
Exercised 1,000 options to buy
@ $21.5, valued at
$21.5k
|
|
| 09/11/2015 |
4
| VEITINGER KLAUS R DR (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS INC|
Txns:
| Sold 500 shares
@ $198.25, valued at
$99.1k
Exercised 500 options to buy
@ $21.5, valued at
$10.8k
|
|
| 08/05/2015 |
4
| VEITINGER KLAUS R DR (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS INC|
Txns:
| Sold 500 shares
@ $261.17, valued at
$130.6k
Exercised 500 options to buy
@ $21.5, valued at
$10.8k
|
|
| 06/12/2015 |
4
| VEITINGER KLAUS R DR (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS INC|
Txns:
| Sold 391 shares
@ $238.21, valued at
$93.1k
Exercised 391 options to buy
@ $21.5, valued at
$8.4k
|
|
| 05/13/2015 |
4
| VEITINGER KLAUS R DR (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS INC|
Txns:
| Sold 158 shares
@ $272.79, valued at
$43.1k
Sold 233 shares
@ $283.3305, valued at
$66k
Exercised 391 options to buy
@ $21.5, valued at
$8.4k
|
|
|
|
|